Clinical Research Directory
Browse clinical research sites, groups, and studies.
Self- Sampling in Cervical Cancer Routine Screening
Sponsor: Tampere University Hospital
Summary
SELF-SAMPLING IN CERVICAL CANCER ROUTINE SCREENING (FALCON) -Study implements a self-sampling option for the non-attendees of the national cervical cancer screening program in the Wellbeing Services County of Pirkanmaa. HPV primary testing is currently preferred method for cervical cancer screening. The HPV-DNA self-sampling has been shown to have screening performance equal to that of provider-obtained samples. In 2024, those turning 30, 35, 40, 45, 50, 55, 60, or 65 had the opportunity to participate in the FALCON study if they do not respond to the first invitation to cervical cancer screening. From March 2025 also women living in Kanta-Häme, Central Finland, Päijät-Häme, and Ostrobothnia can take part to the study. The main objective of the FALCON study is to increase the current coverage of the cervical cancer screening program in the Pirkanmaa, Kanta-Häme, Central Finland, Päijät-Häme, and Ostrobothnia region and assess how acceptable self-sampling is for women.
Official title: Self-Sampling In Cervical Cancer Routine Screening (FALCON)
Key Details
Gender
FEMALE
Age Range
30 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40000
Start Date
2024-06-11
Completion Date
2029-12-31
Last Updated
2025-04-17
Healthy Volunteers
Yes
Conditions
Interventions
self-sampling
increase screening coverage by self-sampling
Locations (1)
Tampere University Hospital and Tampere University
Tampere, Pirkanmaa, Finland